# Hyperbaric Oxygen Effects on Persistent Post-concussive Symptoms

> **NCT05173818** · PHASE2 · COMPLETED · sponsor: **Essentia Health** · enrollment: 20 (actual)

## Conditions studied

- Persistent Post-concussive Syndrome
- Concussion Post Syndrome

## Interventions

- **DRUG:** Hyperbaric oxygen at 1.5 ATA
- **DRUG:** Sham treatment

## Key facts

- **NCT ID:** NCT05173818
- **Lead sponsor:** Essentia Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-28
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-12-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05173818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05173818, "Hyperbaric Oxygen Effects on Persistent Post-concussive Symptoms". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05173818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*